3624 results for «2605»

Filter By

3624 results

Diffuse Coronary Artery Disease: RESTORE DCB – THE HYPER STUDY

18 May 2021 – From EuroPCR 2021

Watch this session presented by Alfonso Lelasi in order to have an update on the treatment of diffuse CAD involving small vessels and/or bifurcation with a novel hybrid (DES and DCB) approach, to understand the rationale of The HYPER Study (NCT03939468), and to know more about third generation RESTORE...

Diffuse Coronary Artery Disease: RESTORE DCB – THE HYPER STUDY

XLIMIT - Randomised controlled trial to assess endothelisation of Xlimus DES

18 May 2021 – From EuroPCR 2021

Watch this session presented by Luca Testa in order to know about XLIMIT randomised clinical trial, and to learn about Xlimus DES stent with Sirolimus and bioabsorbable polymer coating.

XLIMIT - Randomised controlled trial to assess endothelisation of Xlimus DES

Coronary aneurysms: diagnosis, treatment and complications

12 May 2021 – From EuroPCR 2021

Watch this session to increase your knowledge of coronary aneurysms: learn how to avoid side-branch occlusion thanks to covered stent shortening, how to treat left main coronary artery aneurysm, how to handle huge coronary aneurysm in case of DES, and much more!

Coronary aneurysms: diagnosis, treatment and complications

CTO: retrograde approach

12 May 2021 – From EuroPCR 2021

Watch this session if you wish to learn how to handle biradial retrograde CTO PCI, how to manage minimum contrast retrograde CTO PCI in multiple kidney transplantation patient, how to use the Rendezvous Technique, and more!

EuroPCR 2021 CTO: retrograde approach

HIGHLIFE transseptal mitral valve replacement (TSMVR): step by step

18 May 2021 – From EuroPCR 2021

Watch this session presented by Wolfgang Rottbauer in order to learn about the HighLife transseptal mitral valve replacement procedure, to understand the interaction between the devices and the anatomy and to be familiar with upcoming technologies in structural heart procedures.

HIGHLIFE transseptal mitral valve replacement (TSMVR): step by step

Complete revascularisation in patients with acute myocardial infarction

18 May 2021 – From EuroPCR 2021

Watch this session presented by Piroth Zsolt in order to get a quick update on the latest most significant evidence in physiology guided PCI in patients with acute MI, to have a recommendation from an expert on how this assessment can be implemented today compatibly with a IIa...

Complete revascularisation in patients with acute myocardial infarction

What is a healing-targeted drug-eluting stent and how is it different to a normal stent?

18 May 2021 – From EuroPCR 2021

Watch this session presented by Andreas Baumbach and Patrick W. Serruys in order to understand what is a healing-targeted (HT) drug-eluting stent (DES) and what are the potential benefits, to review recent clinical data of the HT DES from the PIONEER III trial, and to learn about...

What is a healing-targeted drug-eluting stent and how is it different to a normal stent?

Patent foramen ovale (PFO) closure with stroke

18 May 2021 – From EuroPCR 2021

Watch this session presented by Engin Bozkurt in order to know more about incidence about stroke caused to younger people, to follow the guideline trend towards patent foramen ovale (PFO) closure, and to learn the future of PFO and device trends.

Patent foramen ovale (PFO) closure with stroke

FFR-guided PCI optimisation directed by high-definition IVUS

18 May 2021 – From EuroPCR 2021

Watch this session presented by Joost Daemen in order to understand the rationale of low post-PCI FFR, to learn if and how post-PCI FFR can be improved, and to know more about the risk of post-PCI optimisation.

FFR-guided PCI optimisation directed by high-definition IVUS

Improving your patient's outcomes with the Edwards Benchmark program

18 May 2021 – From EuroPCR 2021

Watch this session presented by Hélène Eltchaninoff in order to understand the benefit of delivering a standardised care pathway to consistently achieve excellent outcomes, to improve access to high quality of care with safe early discharge for selected patients, in Europe, and to learn how the Edwards Benchmark...

Improving your patient's outcomes with the Edwards Benchmark program

New, novel Navitor TAVI valve with active paravalvular leak-sealing technology

18 May 2021 – From EuroPCR 2021

Watch this session presented by Lars Sondergaard to learn about the latest TAVI active PVL-sealing technology, to understand the clinical evidence with the active PVL-sealing technology, and to discuss the value that the new, novel Navitor valve brings in today's TAVI market.

View the recording of this EuroPCR 2021 Session...

New, novel Navitor TAVI valve with active paravalvular leak-sealing technology

A picture is worth a thousand words: how intravascular imaging can enhance the continuum of care

18 May 2021 – From EuroPCR 2021

Watch this session presented by Giulio Guagliumi and Tina Vilsbøll in order to understand how intravascular imaging can assess patient risk factors, how referring physicians can utilize and patients can benefit from an imaging-guided intervention, and how IVUS+NIRS images can be used as a tool to enhance patient education...

A picture is worth a thousand words: how intravascular imaging can enhance the continuum of care

Guiding primary PCI using high-definition intravascular ultrasound

18 May 2021 – From EuroPCR 2021

Watch this session presented by Joost Daemen in order to understand the pitfalls of primary PCI, to learn how IVUS can improve outcomes, and to understand the importance of plaque and thrombus quantification.

Guiding primary PCI using high-definition intravascular ultrasound

Can a pressure guidewire expand coronary physiology adoption in bifurcations?

18 May 2021 – From EuroPCR 2021

Watch this session presented by Evald Hoi Christiansen in order to review the current major barriers to expand adoption of coronary physiology, to discover the advantages of the OptoWire III pressure guidewire in overcoming part of these barriers supporting in full safety the physiology assessments of complex PCI,...

Can a pressure guidewire expand coronary physiology adoption in bifurcations?

Clinical event reductions in high-risk hypertension patients treated with renal denervation

18 May 2021 – From EuroPCR 2021

Watch this session presented by Roland Schmieder in order to learn about the long-term safety and efficacy of renal denervation in high-risk subgroups from the largest renal denervation data set of real-world patients, to understand how clinical event rates could be reduced following renal denervation as compared...

Clinical event reductions in high-risk hypertension patients treated with renal denervation

Real-world burden of patients with angina undergoing angiography, a population-representative study, FLORIDA

18 May 2021 – From EuroPCR 2021

Watch this session presented by David Leistner in order to learn about a study investigating the long-term burden of patients with angina in a real world cohort, to understand associations between treatment decisions in the catheter laboratory and follow-up interventions, and to know about the kind and frequency...

Real-world burden of patients with angina undergoing angiography, a population-representative study, FLORIDA

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes

18 May 2021 – From EuroPCR 2021

Watch this session presented by Juan F. Iglesias in order to review the role of ultrathin DES in optimising clinical outcomes in STEMI patients, to learn about the BIOSTEMI trial and its new two-year outcomes, and to assess the impact of the BIOSTEMI trial on your daily practice.

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes

RADIANCE-HTN TRIO: key takeaways and implications for the treatment of hypertension

18 May 2021 – From EuroPCR 2021

Watch this session presented by Andrew Sharp in order to learn about the recent clinical advancements in the renal denervation procedure with the Paradise Ultrasound RDN system, and to hear the expert's perspective on the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered to demonstrate BP lowering...

RADIANCE-HTN TRIO: key takeaways and implications for the treatment of hypertension

Early real-world experience with Tendyne™ TMVR

18 May 2021 – From EuroPCR 2021

Watch this session presented by Stephan von Bardeleben in order to learn about real-world Tendyne results from TENDER EU, the largest reported commercial cohort, to hear expert feedback on the safety and effectiveness of Tendyne TMVI in real-life setting, and to discover how one heart team integrates Tendyne...

Early real-world experience with Tendyne™ TMVR

Abluminus DES+: an innovative solution going global to beat diabetes

18 May 2021 – From EuroPCR 2021

Watch this session presented by Roxana Mehran, Luca Testa, Alexandre Abizaid and Marie-Claude Morice in order to know more about the need of a dedicated DES+ for diabetic patients and the technology behind it and the updates on ongoing and upcoming studies and trials, as well...

Abluminus DES+: an innovative solution going global to beat diabetes
Didn’t find what you were looking for?